Globally, about 350 million people are sick with diabetes mellitus, which today remains an incurable disease, despite the fact that various methods of treatment allow doctors to control its course and minimize the complications that accompany the development of diabetes. That is why scientists in many countries continue to actively search for a drug that can cure a patient from such a serious ailment.
About 350 million people are sick with diabetes mellitus, which today remains an incurable disease
Perhaps in the near future, thanks to the research of American scientists from the state of California, we will be able to obtain an absolutely new miracle cure that can permanently save diabetics from a terrible disease and return them to a normal lifestyle.
During experiments on laboratory rodents with diabetes, scientists noticed that one injection of FGF1 protein allows maintaining normal blood sugar levels in animals for two to three days.
Further research has shown that regular injections of this protein can not only control blood sugar levels, but also completely change the body’s sensitivity to insulin, which is an important physiological factor in the development of this disease. Another important advantage of protein injections, is that this treatment, unlike traditional ones, does not cause any side effects.
regular injections of FGF1 protein control blood sugar levels and completely change the body’s sensitivity to insulin
While drugs currently used to treat diabetes, by increasing the level of insulin and reducing the body’s resistance to it, can lower the level of glucose in the blood so much that this can lead to very serious consequences: for example, cause irreversible brain damage. It should be noted that even high doses of the drug administered to sick mice do not cause any side effects.
Important advantage of protein injections, is that this treatment does not cause side effects.
Research by American scientists has demonstrated surprising results: injection of FGF1 protein is able to restore the natural function of regulating insulin and blood sugar levels and keeping glucose concentrations at a safe level. Such results give grounds for the transition of research to a new stage — the stage of clinical trials on patients with diabetes mellitus.